Polygiene AB (publ.) Stock Nasdaq Stockholm
Equities
SE0007692157
Specialty Chemicals
Sales 2024 * | 128M 11.8M | Sales 2025 * | 144M 13.22M | Capitalization | 292M 26.87M |
---|---|---|---|---|---|
Net income 2024 * | -4M -368K | Net income 2025 * | 6M 552K | EV / Sales 2024 * | 2.01 x |
Net cash position 2024 * | 34M 3.13M | Net cash position 2025 * | 38M 3.49M | EV / Sales 2025 * | 1.77 x |
P/E ratio 2024 * |
-72.7
x | P/E ratio 2025 * |
44.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 17-05-09 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 22-09-14 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 18-12-31 | |
Director/Board Member | 71 | 23-05-10 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+11.31% | 62.8B | |
-5.19% | 45.4B | |
+15.01% | 40.32B | |
+17.87% | 25.83B | |
+5.07% | 18.21B | |
+0.04% | 17.41B | |
+4.48% | 15.64B | |
-17.27% | 15.51B | |
-20.22% | 13.42B |